Cargando…

Novel Treatment Pathways in Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a severe and progressive vascular disease characterized by pulmonary vascular remodeling, proliferation, and inflammation. Despite the availability of effective treatments, PAH may culminate in right ventricular failure and death. Currently approved medicatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qaiser, Kanza N., Tonelli, Adriano R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Houston Methodist DeBakey Heart & Vascular Center 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298123/ https://www.ncbi.nlm.nih.gov/pubmed/34326930 http://dx.doi.org/10.14797/CBHS2234

Ejemplares similares

Fluid loading during the hemodynamic evaluation of pulmonary hypertension: a cross-sectional study
por: Qaiser, Kanza N., et al.
Publicado: (2023)

Palliative care in pulmonary arterial hypertension: an underutilised treatment
por: Khirfan, Ghaleb, et al.
Publicado: (2018)

Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis
por: Almaaitah, Saja, et al.
Publicado: (2020)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Perioperative management in patients with pulmonary hypertension
por: Tonelli, Adriano R., et al.
Publicado: (2014)

Leptin levels predict survival in pulmonary arterial hypertension
por: Tonelli, Adriano R., et al.
Publicado: (2012)

Gasometric gradients between blood obtained from the pulmonary artery wedge and pulmonary artery positions in pulmonary arterial hypertension
por: Khirfan, Ghaleb, et al.
Publicado: (2019)

Novel Experimental Therapies for Treatment of Pulmonary Arterial Hypertension
por: Zolty, Ronald
Publicado: (2021)

Molecular Pathways in Pulmonary Arterial Hypertension
por: Shah, Aangi J., et al.
Publicado: (2022)

A review of imaging modalities in pulmonary hypertension
por: Ascha, Mona, et al.
Publicado: (2017)

Is hyponatremia associated with mortality in pulmonary arterial hypertension?
por: Rudkovskaia, Anastasiia A., et al.
Publicado: (2018)

Hypoxemia in patients with idiopathic or heritable pulmonary arterial hypertension
por: Khirfan, Ghaleb, et al.
Publicado: (2018)

Novel biomarkers for pulmonary arterial hypertension
por: Anwar, Anjum, et al.
Publicado: (2016)

Ambrisentan for the treatment of pulmonary arterial hypertension
por: Casserly, Brian, et al.
Publicado: (2009)

Subdural hematomas in pulmonary arterial hypertension patients treated with prostacyclin analogs
por: Louis, Lam, et al.
Publicado: (2012)

Effect of abnormal right heart structures on the diagnosis of pulmonary hypertension
por: AbuHalimeh, Batool, et al.
Publicado: (2018)

Macitentan for the treatment of pulmonary arterial hypertension
por: Kholdani, Cyrus A, et al.
Publicado: (2014)

Pulmonary Arterial Hypertension: Pathophysiology and Treatment
por: Lan, Norris S. H., et al.
Publicado: (2018)

Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension
por: Sánchez-Gloria, José L., et al.
Publicado: (2020)

Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension
por: Martin de Miguel, Irene, et al.
Publicado: (2023)

Nitric oxide deficiency in pulmonary hypertension: Pathobiology and implications for therapy
por: Tonelli, Adriano R., et al.
Publicado: (2013)

Hemodynamic indices in pulmonary hypertension: a narrative review
por: Manek, Gaurav, et al.
Publicado: (2022)

Interventional and Surgical Treatments for Pulmonary Arterial Hypertension
por: Stącel, Tomasz, et al.
Publicado: (2021)

Epoprostenol sodium for treatment of pulmonary arterial hypertension
por: Saito, Yukihiro, et al.
Publicado: (2015)

Recent Advances in the Treatment of Pulmonary Arterial Hypertension
por: Otani, Naoyuki, et al.
Publicado: (2022)

Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension
por: Satoh, Kimio, et al.
Publicado: (2018)

Ambrisentan for the treatment of pulmonary arterial hypertension: improving outcomes
por: Elshaboury, Soha M, et al.
Publicado: (2013)

Perioperative approach to precapillary pulmonary hypertension in non-cardiac non-obstetric surgery
por: Bandyopadhyay, Debabrata, et al.
Publicado: (2021)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension
por: Lang, Irene M., et al.
Publicado: (2015)

Meta-Analysis of Pulmonary Artery Denervation for Treatment of Pulmonary Hypertension
por: Zuo, Wanyun, et al.
Publicado: (2022)

Beyond the evidence: treating pulmonary hypertension in the intensive care unit
por: Bauer, Seth R, et al.
Publicado: (2014)

Treatment of pediatric pulmonary arterial hypertension: A focus on the NO‐sGC‐cGMP pathway
por: Beghetti, Maurice, et al.
Publicado: (2019)

The molecular targets of approved treatments for pulmonary arterial hypertension
por: Humbert, Marc, et al.
Publicado: (2016)

Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children
por: Frank, Benjamin S., et al.
Publicado: (2018)

Pulmonary arterial hypertension: the case for a bioelectronic treatment
por: Ntiloudi, Despοina, et al.
Publicado: (2019)

New progress in diagnosis and treatment of pulmonary arterial hypertension
por: Zhang, Zai-qiang, et al.
Publicado: (2022)

Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension
por: Pullamsetti, Soni Savai, et al.
Publicado: (2023)

Do single or sequential measurements of leptin and adiponectin in plasma have prognostic value in pulmonary arterial hypertension?
por: Tonelli, Adriano R., et al.
Publicado: (2017)

Beyond a single pathway: combination therapy in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2016)

Natural plant products in treatment of pulmonary arterial hypertension
por: Xiang, Lili, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pnedkgrrr9t4vl5t7fm4bm7qil